I read an article linked in Trey's blog. Dr. Drucker mentioned that, "The researchers also found that patients did respond less to Gleevec therapy if they were in a high-risk category due to such factors as an enlarged spleen or a high percentage of immature white cells in their blood."*
I am confused. It appears most of us had an enlarged spleen upon dx. I did. Does this mean I have a poor prognosis on Gleevec, or am I in the 70% for success instead of the avg. 95% (which I understand after 2 months being dx it is probably impossible to tell exactly what my chances are)? I read conflicting information that less than 10% of people dx with CML did not have an enlarged spleen (can dig up that article, but right now I am not sure which one).
Very scared. Not sure I understand exactly what he meant. Is it that the spleen remains large even though taking Gleevec? Luckily, it appears that I did not have many immature white cells in my blood at time of dx.
Could anyone clarify?
*http://www.scienceda...61207160526.htm











